Lung Cancer Considered in Portuguese: Junior Faculty Perspective
As part of IASLC’s Lung Cancer Considered World Language Series, guest host Dr. Maria Cecilia Mathias leads a discussion in Portuguese about the junior faculty perspective with Dr. Maria Thereza Starl...
16 Jan 44min
Lung Cancer Considered: Role of General Media in Lung Cancer Research
In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by CNN Medical Correspondent Meg Tirrell and WTOP reporter Neal Augenstein to discuss the role of the media in lung cancer awa...
6 Jan 31min
Lung Cancer Considered -- Immunotherapy Toxicity: Myths & Pearls
Since the first immunotherapy agent for lung cancer was approved in 2015, this class of drugs has captured the imagination and the narrative for the treatment of driver negative lung cancer. Immunothe...
30 Dec 202518min
Lung Cancer Considered: A New Shot at Progress: Amivantamab Goes SubQ
The FDA has approved subcutaneous amivantamab. Join host Dr. Narjust Florez and guests, Dr. Natasha Leighl and Dr. Federico Cappuzzo, as they explore the science and convenience factor, as well as wh...
23 Dec 202535min
Lung Cancer Considered at the ASCO IASLC 2025 North American Conference on Lung Cancer
In this special episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the IASLC | ASCO 2025 North America Conference on Lung Cancer. Dr. Igor Odintsov disc...
16 Dec 202537min
Lung Cancer Care in New Zealand
In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with two thoracic oncologists practicing in New Zealand—Dr. Laird Cameron from Auckland Hospital and Dr. Annie Wong from the Univ...
9 Dec 202525min
LCC in Spanish: Mujeres and oncologia toracica – Latinoamerica
As part of IASLC’s Lung Cancer Considered World Language Series, host Dr. Narjust Florez leads a Spanish-language discussion with three leaders in thoracic oncology across Latin America: Dr. Mónica Ca...
5 Dec 202547min
IASLC Lung Cancer Considered: ADCs in EGFR Mutant NSCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with Prof. Li Zhang and Dr. Elaine Shum about recent progress in antibody–drug conjugates (ADCs) for EGFR-mutant non-small cell l...
2 Dec 202536min
